Securities Registration: Employee Benefit Plan (s-8)
26 Settembre 2022 - 12:00PM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission
on September 23, 2022
Registration No. 333-__________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES
ACT OF 1933
| SomaLogic, Inc. |
| (Exact name of registrant as specified in its charter) |
| Delaware |
|
52-4298912 |
(State or other jurisdiction of
incorporation or
organization) |
|
(I.R.S. Employer
Identification No.) |
2945 Wilderness Place
Boulder, CO 80301
(Address of Principal Executive Offices, including
Zip Code)
SomaLogic,
Inc. 2021 Omnibus Incentive Plan
(Full title of plan)
Roy Smythe
Chief Executive Officer
SomaLogic, Inc.
2945 Wilderness Place
Boulder, Colorado 80301
(303) 625-9000
(Name, address, including zip code, and telephone
number, including area code, of agent for service)
Copies to:
Charles D. Maguire, Jr.
Tyler F. Mark
Bryan Cave Leighton Paisner LLP
1700 Lincoln Avenue
Denver, CO 80203
(303) 861-7000 |
|
Ruben Gutierrez
General Counsel
2945 Wilderness Place,
Boulder, Colorado 80301
(303) 625-9000 |
Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions
of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging
growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☐ |
Accelerated filer ☐ |
| Non-accelerated filer ☒ |
Smaller reporting company ☒ |
| |
Emerging growth company ☒ |
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 7(a)(2)(B) of the Securities Act ☐
EXPLANATORY NOTE
The number of shares of Common Stock reserved and available for issuance
under the 2021 Omnibus Incentive Plan automatically increase on January 1 of each year commencing on January 1, 2022, in an amount equal
to 5% of the total number of shares of the Registrant’s capital stock outstanding on December 31 of the preceding year, unless the
board of directors of the Registrant acts prior to January 1 of a given year to provide that there will be no such increase for such year
or that the increase for such year will be a lesser number of shares of Common Stock. The amount registered hereby represents the additional
shares reserved and available for issuance under the 2021 Omnibus Incentive Plan on January 1, 2022 and is equal to 5% of the total number
of shares of the Registrant’s capital stock outstanding on December 31, 2021.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
In this registration statement, SomaLogic,, Inc. is sometimes referred
to as “Registrant,” “we,” “us,” or “our.”
As permitted by the rules of the Securities Exchange Commission (“SEC”),
this Registration Statement omits the information specified in Part I of Form S-8. The documents containing the information specified
in Part I of this Registration Statement will be sent or given to eligible employees as specified by Rule 428(b) promulgated under the
Securities Act. Such documents are not being filed with the SEC either as part of this Registration Statement or as prospectuses or prospectus
supplements pursuant to Rule 424 promulgated under the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents
by Reference.
The following documents previously filed by SomaLogic, Inc. (File No.
001-40090) with the SEC are incorporated by reference into this Registration Statement:
| (a) | The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021. |
| (b) | The portions of the Registrant’s Definitive Proxy Statement on Schedule 14A filed with
the SEC on April 25, 2022, that are incorporated by reference into the Registrant’s Annual Report on Form 10-K for the fiscal year
ended December 31, 2021. |
| (d) | The Registrant’s Current Reports on Form 8-K filed on January 5, 2022, February 16, 2022,
March 29, 2022 (Film No. 22780927), June 10, 2022, July 18, 2022, July 27, 2022, August 22, 2022 and August 30, 2022. |
| (e) | The description of the Registrant’s Common Stock which is contained in a registration statement on Form 8-A filed on February
19, 2021 (File No. 001-40090) under the Exchange Act of 1934, as amended (the “Exchange Act”), including any amendment or
report filed for the purpose of updating such description. |
All documents that the Registrant subsequently files pursuant to Sections
13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment to this registration statement which
indicates that all of the shares of Common Stock offered have been sold or which deregisters all of such shares then remaining unsold,
shall be deemed to be incorporated by reference into this registration statement and to be a part hereof from the date of the filing of
such documents; except as to any portion of any future annual or quarterly report to stockholders or document or current report furnished
under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, that is not deemed filed
under such provisions. For the purposes of this registration statement, any statement contained in a document incorporated or deemed to
be incorporated by reference herein shall be deemed to be modified or superseded to the extent that a statement contained herein or in
any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement.
Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this registration
statement.
Under no circumstances will any information filed under current Items
2.02 or 7.01 of Form 8-K, and exhibits furnished on such form that relate to such items, be deemed incorporated herein by reference unless
such Form 8-K expressly provides to the contrary.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
None.
Item 6. Indemnification of Directors and Officers.
Section 145 of the Delaware General Corporation Law (the “DGCL”)
authorizes a court to award, or a corporation’s board of directors to grant, indemnity to directors and officers in terms sufficiently
broad to permit such indemnification under certain circumstances for liabilities, including reimbursement for expenses incurred, arising
under the Securities Act. The Registrant’s amended and restated certificate of incorporation permits indemnification of our directors,
officers, employees, and other agents to the maximum extent permitted by the DGCL, and the Registrant’s amended and restated bylaws
provide that the Registrant will indemnify its directors and executive officers and permit the Registrant to indemnify its other officers,
employees, and other agents, in each case to the maximum extent permitted by the DGCL.
The Registrant has entered into indemnification agreements with its
directors and executive officers, whereby it has agreed to indemnify its directors and executive officers to the fullest extent permitted
by law, including indemnification against expenses and liabilities incurred in legal proceedings to which the director or executive officer
was, or is threatened to be made, a party by reason of the fact that such director or executive officer is or was a director or officer
of the Registrant, if such director or executive officer acted in good faith and in a manner that the director or executive officer reasonably
believed to be in or not opposed to the best interest of the Registrant and, with respect to any criminal action or proceeding, had no
reasonable cause to believe that his or her conduct was unlawful. At present, there is no pending litigation or proceeding involving a
director or executive officer of the Registrant under which indemnification is sought, nor is the Registrant aware of any threatened litigation
that may result in claims for indemnification.
The Registrant maintains insurance policies that indemnify its directors
and executive officers against various liabilities arising under the Securities Act and the Exchange Act that might be incurred by any
director or officer in his or her capacity as such.
Item 7. Exemption from Registration Claimed.
Not applicable.
Item 8. Exhibits.
Reference is made under this Item 8 to the exhibit index included in
this Registration Statement.
Exhibit Index
Item 9. Undertakings.
| 1. | The Registrant hereby undertakes: |
| (a) | To file, during any period in which offers or sales are being made, a post-effective amendment to
this registration statement: |
| (i) | To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |
| (ii) | To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth
in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar
value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum
offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes
in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation
of Registration Fee” table in the effective registration statement; |
| (iii) | To include any material information with respect to the plan of distribution not previously disclosed in the registration statement
or any material change to such information in the registration statement; |
Provided, however, that paragraphs (a)(i) and (a)(ii) do not apply
if the registration statement is on Form S-8 and the information required to be included in a post-effective amendment by those paragraphs
is contained in periodic reports filed with or furnished to the SEC by the Registrant pursuant to Section 13 or Section 15(d) of the Securities
Exchange Act of 1934 that are incorporated by reference in the registration statement.
| (b) | That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
be deemed to be the initial bona fide offering thereof. |
| (c) | To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
termination of the offering. |
| 2. | The Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of
the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable,
each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is
incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities
offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. |
| 3. | Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that
a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director,
officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director,
officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel
the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification
by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue. |
Signatures
Pursuant to the requirements of the Securities Act of 1933, as amended,
the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Boulder,
Colorado, on September 23, 2022.
| |
SOMALOGIC, INC. |
| |
|
| |
By: |
/s/ Roy Smythe |
| |
|
Roy Smythe |
| |
|
Chief Executive Officer |
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature
appears below does hereby constitute and appoint Shaun Blakeman and Ruben Gutierrez and each of them, with full power of substitution
and full power to act without the other, his or her true and lawful attorney-in-fact and agent to act for him or her in his or her name,
place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this registration
statement, and to file this registration statement, with all exhibits thereto, and other documents in connection therewith, with the SEC,
granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing
requisite and necessary to be done in order to effectuate the same as fully, to all intents and purposes, as they or he or she might or
could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, may lawfully do or cause
to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration
statement has been signed by the following persons in the capacities and on the date indicated.
| Signature |
|
Title |
|
Date |
| |
|
|
|
|
| /s/ Roy Smythe |
|
Chief Executive Officer and Director |
|
September 23, 2022 |
| Roy Smythe |
|
(Principal Executive Officer) |
|
|
| |
|
|
|
|
| /s/ Shaun Blakeman |
|
Chief Financial Officer |
|
September 23, 2022 |
| Shaun Blakeman |
|
(Principal Financial and Accounting Officer) |
|
|
| |
|
|
|
|
| /s/ Robert Barchi |
|
Director |
|
September 23, 2022 |
| Robert Barchi |
|
|
|
|
| |
|
|
|
|
| /s/ Eli Casdin |
|
Director |
|
September 23, 2022 |
| Eli Casdin |
|
|
|
|
| |
|
|
|
|
| /s/ Troy Cox |
|
Director |
|
September 23, 2022 |
| Troy Cox |
|
|
|
|
| |
|
|
|
|
| /s/ Charles M. Lillis |
|
Director |
|
September 23, 2022 |
| Charles M. Lillis |
|
|
|
|
| |
|
|
|
|
| /s/ Anne Margulies |
|
Director |
|
September 23, 2022 |
| Anne Margulies |
|
|
|
|
| |
|
|
|
|
| /s/ Ted Meisel |
|
Director |
|
September 23, 2022 |
| Ted Meisel |
|
|
|
|
| |
|
|
|
|
| /s/ Richard Post |
|
Director |
|
September 23, 2022 |
| Richard Post |
|
|
|
|
II-5
Grafico Azioni CM Life Sciences II (NASDAQ:CMII)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni CM Life Sciences II (NASDAQ:CMII)
Storico
Da Giu 2023 a Giu 2024
